Myron M Levine Selected Research

Paratyphoid Fever

1/2017	Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.
7/2007	Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myron M Levine Research Topics

Disease

41	Infections 01/2022 - 03/2003
29	Typhoid Fever (Typhoid) 01/2022 - 01/2003
23	Diarrhea 12/2021 - 04/2002
13	Measles 01/2022 - 05/2003
9	Bacillary Dysentery (Shigellosis) 01/2021 - 01/2003
9	Cholera 11/2019 - 11/2012
8	Fever (Fevers) 01/2019 - 04/2002
7	Gastroenteritis 01/2021 - 08/2010
7	Salmonella Infections (Salmonellosis) 11/2018 - 04/2012
6	Bacteremia 01/2017 - 02/2009
5	Inflammation (Inflammations) 01/2021 - 05/2008
4	Ebola Hemorrhagic Fever 12/2019 - 02/2015
4	Communicable Diseases (Infectious Diseases) 01/2012 - 03/2007
3	Vesicular Stomatitis 01/2017 - 08/2015
3	Tetanus 01/2016 - 03/2004
3	Pneumococcal Infections 05/2006 - 12/2002
2	Pneumonia (Pneumonitis) 12/2021 - 01/2018
2	Dysentery 01/2021 - 05/2016
2	Poliomyelitis (Polio) 01/2021 - 03/2004
2	Paratyphoid Fever 01/2017 - 07/2007
2	Human Influenza (Influenza) 01/2017 - 01/2016
2	Vaccinia 04/2016 - 01/2016
2	Pain (Aches) 01/2016 - 01/2016
2	Tularemia 08/2015 - 04/2009
2	Gastritis 05/2014 - 01/2014
2	Sepsis (Septicemia) 05/2014 - 12/2009
2	Diphtheria 09/2006 - 03/2004
2	Whooping Cough (Pertussis) 09/2006 - 03/2004
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Coinfection 01/2021
1	Malaria 01/2019
1	Cryptosporidiosis 01/2019
1	Giardiasis 01/2019
1	Achlorhydria (Hypochlorhydria) 01/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 11/2016
1	Gallstones (Gallstone) 11/2016

Drug/Important Bio-Agent (IBA)

77	VaccinesIBA 01/2022 - 04/2002
16	AntibodiesIBA 01/2022 - 05/2003
10	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 06/2005
10	AntigensIBA 11/2018 - 01/2003
9	Polysaccharides (Glycans)IBA 07/2018 - 08/2004
7	Immunoglobulin G (IgG)IBA 01/2021 - 08/2004
6	Conjugate VaccinesIBA 01/2022 - 12/2002
6	cholera vaccine CVD 103-HgRIBA 10/2020 - 01/2014
6	DNA VaccinesIBA 03/2009 - 01/2003
5	Lysergic Acid Diethylamide (LSD)IBA 01/2021 - 01/2016
5	Cholera Vaccines FDA Link 11/2018 - 05/2006
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2005
5	Measles VaccineIBA 07/2011 - 07/2005
4	Neutralizing AntibodiesIBA 01/2021 - 05/2003
4	Drinking WaterIBA 11/2020 - 07/2017
4	O Antigens (O Antigen)IBA 11/2019 - 08/2004
4	Attenuated VaccinesIBA 12/2018 - 12/2013
4	SolutionsIBA 05/2014 - 07/2013
4	EnzymesIBA 05/2014 - 07/2005
3	CytokinesIBA 01/2022 - 03/2009
3	Immunoglobulin M (IgM)IBA 11/2019 - 07/2011
3	Immunoglobulin A (IgA)IBA 11/2019 - 01/2017
3	Cholera ToxinIBA 11/2019 - 01/2017
3	Enterotoxins (Enterotoxin)IBA 01/2019 - 02/2012
3	GlycoconjugatesIBA 07/2018 - 04/2012
3	FlagellinIBA 01/2017 - 10/2011
3	Glycoproteins (Glycoprotein)IBA 04/2016 - 05/2006
3	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2016 - 03/2003
3	ImmunosorbentsIBA 05/2014 - 07/2005
3	Rotavirus VaccinesIBA 04/2012 - 08/2010
2	PepsinogensIBA 01/2021 - 10/2020
2	Tetanus Antitoxin FDA Link 01/2021 - 09/2006
2	Blood Group Antigens (Blood Groups)IBA 11/2019 - 01/2017
2	LipopolysaccharidesIBA 11/2018 - 05/2014
2	Capsules (Microcapsules)IBA 07/2018 - 04/2012
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 01/2016
2	Bacterial VaccinesIBA 01/2017 - 02/2009
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017 - 08/2015
2	Combined VaccinesIBA 06/2015 - 03/2004
2	16S Ribosomal RNAIBA 02/2015 - 06/2014
2	Pepsinogen A (Pepsinogen)IBA 05/2014 - 01/2014
2	ZincIBA 07/2013 - 07/2013
2	Secretory Immunoglobulin A (SIgA)IBA 03/2011 - 11/2008
2	Hemagglutinins (Hemagglutinin)IBA 05/2006 - 08/2005
1	Complement System Proteins (Complement)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Immune Sera (Antisera)IBA 01/2021
1	A 17 (A-17)IBA 11/2020
1	Monoclonal AntibodiesIBA 12/2019
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2019
1	Malaria VaccinesIBA 01/2019
1	heat stable toxin (E coli)IBA 01/2019
1	tartrate-sensitive acid phosphataseIBA 11/2018
1	EpitopesIBA 07/2018
1	SandIBA 01/2018
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 01/2016
1	InterferonsIBA 01/2016

Therapy/Procedure

5	Fluid Therapy (Oral Rehydration Therapy) 05/2016 - 04/2008
2	Therapeutics 12/2019 - 05/2014
2	Traction 01/2017 - 01/2012
1	Treatment Delay 01/2018